Better detection. Clinically superior. Low dose.**
What if we could find breast cancers earlier? See lesions more clearly? Reduce the number of unnecessary biopsies?
Questions like these inspired Hologic researchers and scientists to develop Hologic 3D Mammography™ technology. With the introduction of Selenia Dimensions, we launched the first commercially available system that delivers on the extraordinary promise of breast tomosynthesis.
Over half of the U.S. News and World Report top 20 cancer hospitals offer Hologic 3D Mammography™ technology. More than five million women to date in the United States have already been screened with this life-changing technology, which is now available in 50 states and in over 50 countries.
Selenia Dimensions system's Genius™ 3D Mammography™ exam: Simply a better mammogram.
Hologic has always been at the forefront of breast cancer screening and offers the first breast tomosynthesis technology with proven superior clinical performance to 2D mammography.1,4 The revolutionary Selenia Dimensions system, which has set the standard in mammography screening, provides:
- Exceptionally sharp images.
- Seamless transition between imaging modes.
- Sophisticated user tools that simplify operation.
- Advanced clinical applications.
- The world's first and only tomosynthesis-guided biopsy.
- Ergonomic design for patient comfort and ease of operation.
In addition, the Selenia Dimensions system's Genius™ 3D Mammography™ exam offers the only breast tomosynthesis technology with the following advantages over 2D mammography, proving that not all tomo is the same:
- Proven to detect 20%-65% more invasive breast cancers compared to 2D alone, an average increase of 41%.1
- Proven to reduce callbacks by up to 40% compared to 2D alone.2-3
- FDA approved as superior for women with dense breasts compared to 2D alone.2,4
Fast, low dose and clinically superior, compared to 2D. 3D Mammography™ exams: Powered by C-View™ software.
Hologic has further advanced breast cancer screening by producing 2D images from breast tomosynthesis data using C-View software, resulting in a Low Dose Genius™ 3D Mammography™ exam with superior clinical performance compared with 2D alone.4
This Low Dose Genius™ 3D Mammography™ exam is performed in a rapid 3.7-second scan time for greater patient comfort and low patient dose, due to the elimination of 2D X-ray exposures. The synthetic 2D images and 3D™ slices are reviewed together to make clinical decisions or diagnoses part of the Genius™ 3D Mammography™ screening exam.
The Selenia Dimensions system is available in multiple packages and options to meet your facility's unique needs, all without compromising clinical performance:
- Selenia Dimensions 3000 - The evergreen 2D system that offers the benchmark Hologic customers expect, with essential ergonomics and functional workflow features at an attractive price. Plus, the Selenia Dimensions system 3000 package offers the agility to evolve with you.
- Selenia Dimensions 3D™ Performance System - The 3D™ system that offers the benchmark Hologic customers expect, with essential ergonomics and functional workflow features, as well as the Genius™ 3D Mammography™ exam, at an attractive price.
- Selenia Dimensions 6000 - The 2D/3D™ system that redefines ergonomics, matched with the perfect balance of enhanced workflow features, taking your performance to the next level.
- Selenia Dimensions 9000 - The premium 2D/3D™ system that delivers on high performance through its outstanding, optimal ergonomics and elevated, intelligent workflow features that amplify your performance.
Streamlining workflow, the Selenia Dimensions system performs the imaging of tomorrow, today. All configurations offer the following features.
- Images that can be instantly viewed on a 2MP or 3MP DICOM-calibrated display, providing exceptionally fine detail.
- Allows prior breast imaging studies to be recalled, making it possible to view new and prior images side-by-side.
Optimized face shield:
- Retractable to help when positioning patients.
- Stationary during 3D™ imaging, allowing patients to be positioned as they are for 2D imaging.
FAST Paddle™ system:
- Conforms to natural contours of the breast, providing greater comfort to the patient and more even compression across the entire breast.
- All paddles used for 2D and 3D™ imaging.
Streamlined tube head:
- Streamlined tube head and ample source-to-image distance (SID) of 70 cm, making positioning easier and providing more space for interventional procedures.
Multiple procedure modes:
- 2D mammography
- Genius™ 3D Mammography™ exam
- Low Dose Genius™ 3D Mammography™ exam
- 3D Mammography™ only
- 2D or 3D™ biopsy with the Affirm® breast biopsy guidance system
- I-View™ software for contrast enhanced 2D imaging
Each system is capable of interventional procedures using the Affirm breast biopsy guidance system. The system offers both stereotactic and 3D™ biopsy procedure options.*
*Additional purchase may be required.
FDA Approves Pfizer COVID-19 Boosters for Older and At-Risk People
Today, 23 September, the US FDA amended the EUA for the Pfizer-BioNTech... Read more
Two Doses Make Johnson & Johnson COVID-19 Vaccine 94% Effective
In July, New York University researchers published results (Tada et. al,... Read more
Pfizer Says COVID-19 Vaccine Safe for Children Ages 5 and Up
Given that children and adolescents can get sick with COVID-19, attending... Read more
JOIN OUR MANAGEMENT COMMUNITY
EFRS and EuSoMII Announce Partnership and Sign a Memorandum of Understanding
The European Society of Medical Imaging Informatics (EuSoMII) and t Read more
Artificial Intelligence for Quick and Precise Echocardiography
The quantification and efficiency of performing measurements can be a... Read more
iCAD Signs Global Distribution Agreement with Sectra
Agreement will expand access to ProFound AI and ProFound AI Risk to more... Read more
New AMA President: Dr Susan Bailey
The 175th president of the American Medical Association (AMA),... Read more
Oliver Reichardt, RCR‘s New Chief Executive
As of May 4, Oliver Reichardt is new Chief Executive of t he... Read more
Dr. Sebastian Krolop appointed Chief Operating & Strategy Officer of HIMSS
Dr. Sebastian Krolop, M.D., Ph.D., M. Sc. has recently been appointed the... Read more
Dr. Paul Wischmeyer earns prestigious FASPEN award
The American Society for Parenteral and Enteral Nutrition (ASPEN) has... Read more
John Ormiston Awarded the EuroPCR 2017 Ethica Award
The 2017 Ethica Award, the highest honour of the European cardiovascular... Read more
Gamma Medica Bolsters Executive Team to Support Fight Against Breast Cancer
Gamma Medica, a leader in molecular breast imaging (MBI) technology, announced... Read more
JOIN OUR MANAGEMENT COMMUNITY
JOIN OUR MANAGEMENT COMMUNITY